Magenta Therapeutics is a clinical-stage biotech developing therapeutics to curative power of stem cell transplants to more patients
Total raised: $150.5M
Founded date: 2016
Investors 3
| Date | Name | Website |
| - | EcoR1 Capi... | ecor1cap.c... |
| - | Atlas Vent... | atlasventu... |
| - | GV | gv.com |
Funding Rounds 3
| Date | Series | Amount | Investors | Deal News |
| 09.04.2018 | Series C | $52M | - | finsmes.co... |
| 02.05.2017 | Series B | $50M | - | citybizlis... |
| 16.11.2016 | Series A | $48.5M | - | citybizlis... |
Mentions in press and media 24
| Date | Title | Description | Source |
| 14.05.2021 | MAGENTA THERAPEUTICS, INC. Magenta Therapeutics : Announces... | Magenta Therapeutics Announces $86.4 Million Common Stock Investment from Multiple Investors CAMBRI... | marketscre... |
| 12.05.2021 | MAGENTA THERAPEUTICS, INC. Magenta Therapeutics : Announces... | Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel m... | marketscre... |
| 01.12.2020 | Slone Partners Places Kevin B. Johnson as Senior Vice Presid... | “Dr. Johnson is an experienced industry leader with extensive knowledge of the current regulatory la... | prweb.com/... |
| 13.09.2020 | Акции, стартапы, недвижимость: куда инвестируют Гарвард, Йел... | Активы шести университетских фондов — около $178 млрд. Среди их инвестиций компании вроде Google, Fa... | vc.ru/fina... |
| 06.05.2020 | AVROBIO and Magenta Therapeutics Announce Collaboration to E... | Collaboration focuses on advancing innovation with antibody-drug conjugate (ADC)-based conditioning ... | svhealthin... |
| 10.04.2018 | Term Sheet — Tuesday, April 10 | BIKE SHARING WARS The bike-sharing war is roaring in the United States following its explosive popu... | fortune.co... |
| 09.04.2018 | Magenta Therapeutics Secures $52M in Series C Financing | Magenta Therapeutics, a Cambridge, MA-based biotechnology company developing novel medicines, comple... | finsmes.co... |
| 09.04.2018 | Magenta Therapeutics Secures $52M in Series C | CAMBRIDGE, MA, Biotechnology company developing novel medicines to bring the curative power of bon... | vcnewsdail... |
| 09.04.2018 | Magenta Therapeutics Secures $52 Million in Series C Financi... | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Magenta Therapeutics, a biotechnology company developing novel me... | citybizlis... |
| 21.02.2018 | Top Pfizer research exec John Davis joins migration to ... | John Davis Sue Dillon isn’t the only Big Pharma R&D exec to make news this week after mak... | endpts.com... |
Show more